Opiant Pharmaceuticals, Inc.
(NASDAQ : OPNT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
0.16%46.508.1%$739.78m
AMGNAmgen Inc.
0.35%176.741.3%$505.37m
CELGCelgene Corporation
0.01%91.771.3%$444.24m
GILDGilead Sciences, Inc.
-1.38%67.130.9%$405.79m
BIIBBiogen Inc.
-0.35%232.811.3%$386.33m
ILMNIllumina, Inc.
-0.02%302.223.5%$335.70m
REGNRegeneron Pharmaceuticals, Inc.
-0.15%297.752.6%$277.74m
SRPTSarepta Therapeutics, Inc.
-2.70%152.6814.7%$203.24m
ALXNAlexion Pharmaceuticals, Inc.
0.64%123.832.0%$199.42m
VRTXVertex Pharmaceuticals Incorporated
0.16%176.661.9%$187.79m
EXASExact Sciences Corporation
-0.38%115.7524.1%$139.96m
AAgilent Technologies, Inc.
-1.08%69.791.6%$133.81m
INCYIncyte Corporation
-1.23%80.392.5%$114.67m
BLUEBluebird Bio, Inc.
-1.57%133.6314.3%$97.66m
BMRNBioMarin Pharmaceutical Inc.
-1.88%82.414.3%$87.68m

Company Profile

Opiant Pharmaceuticals, Inc. engages in the development of pharmaceutical solutions for common addictions and related disorders. It focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. Opiant Pharmaceuticals was founded on June 21, 2005 and is headquartered in Santa Monica, CA.